Skip to main content
ALKS
NASDAQ Life Sciences

Experimental Narcolepsy Drug Shows Positive Wakefulness Results for Alkermes

Tom Rudovsky · Reported by Binance News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$44.09
Mkt Cap
$7.419B
52W Low
$25.165
52W High
$45.76
52W Position info
75% above low
Off High info
3.6% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

ALKS sits 75% above its 52-week low of $25.165.

Summary

Alkermes announced positive trial results for an experimental drug, demonstrating improved wakefulness and reduced daytime sleepiness in patients with narcolepsy. This adds to a series of positive drug development news for the company, following positive Phase 3 results for LUMRYZ in narcolepsy in May and Orphan Drug Designations for alixorexton in June. Positive clinical data for a new drug candidate in a significant therapeutic area like narcolepsy can materially enhance the company's pipeline value and future revenue potential.

At the time of this announcement, ALKS was trading at $44.09 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.4B. The 52-week trading range was $25.17 to $45.76. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Binance News.


Price Chart

Share this article

Copied!

ALKS - Latest Insights

ALKS
Nov 03, 2026, 9:20 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $45.35
Real-time Price: $44.00 info
Change: -$1.35 (-3%) info
Market Cap: $7.485B info
ALKS
Nov 03, 2026, 7:05 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $45.50
Real-time Price: $44.00 info
Change: -$1.50 (-3%) info
Market Cap: $7.485B info
ALKS
Sep 21, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $43.45
Real-time Price: $44.00 info
Change: +$0.550 (+1%) info
Market Cap: $7.485B info
ALKS
Aug 03, 2026, 4:08 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $49.53
Real-time Price: $44.00 info
Change: -$5.53 (-11%) info
Market Cap: $7.485B info
ALKS
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $49.51
Real-time Price: $44.00 info
Change: -$5.51 (-11%) info
Market Cap: $7.485B info